Ligand validation:9MHQ

VOV: harderoheme (III)

VOV is a Ligand Of Interest in 9MHQ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9MHQ_VOV_C_501	100%	50%	0.047	0.991	0.79	1.14	1	6	2	1	100%	0.91
9MHQ_VOV_D_301	100%	53%	0.049	0.991	0.75	1.05	-	2	4	1	100%	0.78
9MHQ_VOV_B_401	99%	51%	0.057	0.986	0.8	1.08	1	3	3	1	100%	0.75
9MHQ_VOV_E_401	99%	52%	0.059	0.987	0.79	1.07	1	3	6	1	100%	0.72
9MHQ_VOV_A_301	98%	51%	0.063	0.983	0.77	1.1	1	3	4	1	100%	0.72
9MHR_VOV_D_301	93%	48%	0.08	0.976	0.82	1.16	2	5	1	1	100%	1
9MIQ_VOV_B_301	86%	41%	0.095	0.964	0.89	1.41	1	11	1	1	100%	1
6FXQ_VOV_D_302	54%	29%	0.153	0.916	1.43	1.39	5	9	0	1	100%	0.29
6XUB_VOV_E_401	35%	29%	0.191	0.88	1.45	1.37	6	11	2	1	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.